StemCells, Inc. Reports Fourth Quarter and Full Year 2014 Financial Results and Provides Business Update

Go back to StemCells, Inc. Reports Fourth Quarter and Full Year 2014 Financial Results and Provides Business Update

StemCells (STEM) Misses Q3 EPS by 2c

March 16, 2015 4:08 PM EDT

StemCells (NASDAQ: STEM) reported Q3 EPS of ($0.14), $0.02 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $883 million versus the consensus estimate of $220 million.

For earnings history and earnings-related data on StemCells (STEM) click here.

... More